FMR CORP 13D and 13G filings for Foghorn Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:28 am Sale |
2024-12-31 | 13G | Foghorn Therapeutics Inc. FHTX |
FMR CORP | 5,689,719 10.200% |
-613,498 (-9.73%) |
Filing |
| 2024-06-10 09:48 am Purchase |
2024-06-07 | 13G | Foghorn Therapeutics Inc. FHTX |
FMR CORP | 6,303,217 11.392% |
3,493,208 (+124.31%) |
Filing |
| 2024-02-09 09:03 am Sale |
2024-02-08 | 13G | Foghorn Therapeutics Inc. FHTX |
FMR CORP | 2,810,009 6.656% |
-307,385 (-9.86%) |
Filing |
| 2023-02-09 10:59 am Purchase |
2023-02-09 | 13G | Foghorn Therapeutics Inc. FHTX |
FMR CORP | 3,117,394 7.457% |
632,560 (+25.46%) |
Filing |
| 2022-02-09 09:20 am Sale |
2022-02-08 | 13G | Foghorn Therapeutics Inc. FHTX |
FMR CORP | 2,484,834 6.699% |
-95,800 (-3.71%) |
Filing |
| 2021-02-08 10:21 am Purchase |
2021-02-05 | 13G | Foghorn Therapeutics Inc. FHTX |
FMR CORP | 2,580,634 7.041% |
2,580,634 (New Position) |
Filing |